EN
中文 EN
Innovation for a safer world
CanSinoBIO is an industry-leading biopharmaceutical company dedicated to providing global solutions for the prevention and treatment of infectious diseases through research & development, manufacturing and commercialization of vaccine products for human use.
More
5
Marketed products
5
Technology platforms
10+
Diseases preventing
Innovation
Customer First
Global Vision
Advanced Technology
Prospects
News
102024
Media Report
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
More
082024
Media Report
CanSinoBIO Reports Outstanding H1 2024 Performance
More
062024
Company News
CanSinoBIO Executives Talk with WHO Experts on the Development Progress of Polio Vaccines
More
042024
Company News
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
More
032024
Company News
CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia
More
Social Responsibility
As a leading company in innovative vaccine research and development, we are unwavering in our commitment to providing global solutions for the prevention and treatment of infectious diseases. We fulfil our social responsibilities by consistently providing high-quality vaccines and contributing to global public health.
More
Marketed Products
Menhycia®
More
Convidecia®
 More
Menphecia®
 More
Convidecia Air®
 More